India, June 9 -- Agilus Diagnostics, subsidiary of Fortis Healthcare, has launched the automated Idylla molecular diagnostics system at its Goregaon laboratory in Mumbai, enabling rapid detection of cancer-related genetic mutations within 2.5 to 3 hours.

The launch marks a significant advancement in accelerating clinical decision-making and expanding access to precision oncology in India.

The Idylla system is a fully integrated, cartridge-based molecular testing platform that combines sample processing, nucleic acid extraction, amplification and detection into a single automated workflow. By minimising manual intervention and pre-analytical variability, the system delivers highly accurate and reproducible results in a significantly shor...